ArticlePhytochemistry reviews : proceedings of the Phytochemical Society of Europe2008
Transgenic plants for animal health: plant-made vaccine antigens for animal infectious disease control.
Article in Phytochemistry reviews : proceedings of the Phytochemical Society of Europe, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.
- A meta-analysis: the efficacy and effectiveness of polypeptide vaccines protect pigs from foot and mouth disease.Scientific reports · 2022Pooled it
- The Plant Viruses and Molecular Farming: How Beneficial They Might Be for Human and Animal Health?International journal of molecular sciences · 2023Review
- Article
- Plant-Produced Vaccines: Future Applications in Aquaculture.Frontiers in plant science · 2021Review
- The potential of plant systems to break the HIV-TB link.Plant biotechnology journal · 2019Review
- Recombinant Plant Engineering for Immunotherapeutic Production.Current molecular biology reports · 2017Review
- Plant-based oral vaccines against zoonotic and non-zoonotic diseases.Plant biotechnology journal · 2016Review
- Farming of Plant-Based Veterinary Vaccines and Their Applications for Disease Prevention in Animals.Advances in virology · 2015Review
- Plant-based solutions for veterinary immunotherapeutics and prophylactics.Veterinary research · 2014Review
- Plant biotechnology for food security and bioeconomy.Plant molecular biology · 2013Article
- How can plant genetic engineering contribute to cost-effective fish vaccine development for promoting sustainable aquaculture?Plant molecular biology · 2013Review
- Protein body formation in stable transgenic tobacco expressing elastin-like polypeptide and hydrophobin fusion proteins.BMC biotechnology · 2013Article
- Hydrophobin fusions for high-level transient protein expression and purification in Nicotiana benthamiana.Plant physiology · 2010Article
- High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants.Planta · 2010Article
- Expression and purification of an anti-Foot-and-mouth disease virus single chain variable antibody fragment in tobacco plants.Transgenic research · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A variety of plant species have been genetically modified to accumulate vaccine antigens for human and animal health and the first vaccine candidates are approaching the market. The regulatory burden for animal vaccines is less than that for human use and this has attracted the attention of researchers and companies, and investment in plant-made vaccines for animal infectious disease control is increasing. The dosage cost of vaccines for animal infectious diseases must be kept to a minimum, especially for non-lethal diseases that diminish animal welfare and growth, so efficient and economic production, storage and delivery are critical for commercialization. It has become clear that transgenic plants are an economic and efficient alternative to fermentation for large-scale production of vaccine antigens. The oral delivery of plant-made vaccines is particularly attractive since the expensive purification step can be avoided further reducing the cost per dose. This review covers the current status of plant-produced vaccines for the prevention of disease in animals and focuses on barriers to the development of such products and methods to overcome them.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.